Top of the morning to you. A sunny day is unfolded over the Pharmalot corporate campus, where our official mascots are fertilizing the weeds, the short people are heading off to their schoolhouses and the cup of stimulation is brewing in our official cafeteria. All of which means we are in the thick of our routine. And what a routine - there are documents to read, phone calls to make, e-mails to write and meetings to arrange. We know you can relate. So here are some tidbits to get you started. Hope your day goes well and keep us in mind if you hear something interesting...
FDA Wants Limits On Antibiotics Given To Livestock (Associated Press)
Abbott's Humira Will Become Biggest-Selling Drug (Reuters)
Japan's Takeda To Buy URL Pharma For $800M (Reuters)
India's Proposed Drug Marketing Policy Remains In Limbo (Economic Times)
US Court Invalidates Two Sanofi Taxotere Patents (Reuters)
Illumina Gets Boost From Another Proxy Advisor In Roche Fight (Pharma Times)
Judge Weighs Bid To Block Express Scripts-Medco Deal (Bloomberg News)
Amgen To Buy KAI Pharma For $315M (San Francisco Business Journal)
Abbott's Humira Wins EC Approval For Ulcerative Colitis (Bloomberg News)
Omega-3 Pills May Not Thwart Heart Disease (Reuters)
ACRO India Criticizes Media Coverage (Pharma Times)
India Strengthens Clinical Trial Oversight (Outsourcing Pharma)
Teva Given Tax Credit For Proposed R&D Facility In New Jersey (Star-Ledger of New Jersey)
EDITOR'S NOTE: Please check this post for updates throughout the day
steaming coffee pic thx to dleggett on flickr
1 Comment
In honor of the Reuters study, a coincidental morning offering of "humor?" (You may decide...)
http://www.gocomics.com/closetohome/2012/04/11